Running interference to lower cholesterol
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference13 articles.
1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials;Lancet,2010
2. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Reiner;Eur Heart J,2011
3. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation;Smith;Circulation,2011
4. The PCSK9 decade;Lambert;J Lipid Res,2012
5. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease;Cohen;N Engl J Med,2006
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases;Nature Communications;2019-04-30
2. PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol;Mini-Reviews in Medicinal Chemistry;2018-12-06
3. Manipal diabetes coronary artery severity score;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2017-11
4. Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives;European Heart Journal;2017-04-18
5. Inclisiran. RNAi therapeutic targeting PCSK9, Treatment of hypercholesterolemia;Drugs of the Future;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3